Kfir Schreiber is the founder of DeepCure. DeepCure has raised $72M in total funding. Latest round: Series A. Backed by IAG Capital Partners.
Kfir Schreiber is the Co-Founder and CEO of DeepCure, a Boston-based small molecule drug discovery company. He co-founded the company in 2018, aiming to develop therapeutics for inflammation and autoimmune diseases using machine learning, physics-based simulations, and chemistry automation.
Full founder directory · Investor directory · Company funding database · Fundraising library